Clorox stock is rated 'sell' amid weak growth, valuation concerns, and market challenges. Learn why fundamentals don't ...

Clorox faces headwinds from ERP transition, declining sales, and margin pressure, but most negatives appear priced in. Click ...

Here’s what you need to know about the “mystery liquids” being sold to cost-cutters and unqualified injectors.

A Richmond region Fortune 500 firm, Owens & Minor Inc., is getting a lot smaller, with an agreement to sell the business that accounts for three-quarters of its revenue.